Literature DB >> 8841434

Cell susceptibility to apoptosis by glutamine deprivation and rescue: survival and apoptotic death in cultured lymphoma-leukemia cell lines.

P G Petronini1, S Urbani, R Alfieri, A F Borghetti, G G Guidotti.   

Abstract

Human leukemia/lymphoma cells maintained in culture medium without provision of fresh nutrients lose viability and die by a process resembling apoptosis within a few days. Upon incubation in an FCS-supplemented RPMI 1640 medium containing 2 mM L-glutamine CEM, Namalwa, HL-60 and U937 cells, seeded at initial densities of 0.2 to 1 x 10(6) cells/ml, ceased growing within 3-5 days and progressively entered an apoptotic pathway, as assessed by nucleosomal DNA fragmentation and morphology. Both the major energy-source nutrients in the medium, glucose and glutamine, became rapidly exhausted during the incubation. Further studies were performed using CEM cells. Incubation in glutamine-free or glucose-free medium renewed every 24 h showed that glutamine deprivation is associated with cell death by apoptosis independent of energetic failure, whereas glucose deprivation is followed by rapid loss of mitochondrial function with sharp drop of intracellular ATP and cell death by necrosis. A 12-24 h incubation in glutamine-depleted medium was required to direct the cells toward the apoptotic pathway. Growth arrest followed by apoptotic death was detected in CEM cells when medium glutamine concentration remained below 0.3-0.4 mM for at least 24 h, but a reinstatement of medium glutamine to 2 mM within this period rescued the cells from growth arrest and death.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8841434     DOI: 10.1002/(SICI)1097-4652(199610)169:1<175::AID-JCP18>3.0.CO;2-C

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  11 in total

1.  Combinatorial antitumor effects of amino acids and epigenetic modulations in hepatocellular carcinoma cell lines.

Authors:  Yasmine A Hassan; Maged W Helmy; Asser I Ghoneim
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-08-20       Impact factor: 3.195

2.  Pharmacology, immunogenicity, and efficacy of a novel pegylated recombinant Erwinia chrysanthemi-derived L-asparaginase.

Authors:  Wei-Wen Chien; Soraya Allas; Nicolas Rachinel; Pierre Sahakian; Michel Julien; Céline Le Beux; Claire-Emmanuelle Lacroix; Thierry Abribat; Gilles Salles
Journal:  Invest New Drugs       Date:  2014-05-15       Impact factor: 3.850

3.  Effects of n-3 fatty acid, fructose-1,6-diphosphate and glutamine on mucosal cell proliferation and apoptosis of small bowel graft after transplantation in rats.

Authors:  Xiao-Ting Wu; Jie-Shou Li; Xiao-Fei Zhao; Ning Li; Yu-Kui Ma; Wen Zhuang; Yong Zhou; Gang Yang
Journal:  World J Gastroenterol       Date:  2003-06       Impact factor: 5.742

4.  The effect of the catalytic topoisomerase II inhibitor dexrazoxane (ICRF-187) on CC9C10 hybridoma viability and productivity.

Authors:  N Barnabé; M Butler; B B Hasinoff
Journal:  Cytotechnology       Date:  2001-10       Impact factor: 2.058

Review 5.  Targeting Glutamine Induces Apoptosis: A Cancer Therapy Approach.

Authors:  Lian Chen; Hengmin Cui
Journal:  Int J Mol Sci       Date:  2015-09-22       Impact factor: 5.923

Review 6.  Hopefully devoted to Q: targeting glutamine addiction in cancer.

Authors:  Emma R Still; Mariia O Yuneva
Journal:  Br J Cancer       Date:  2017-04-25       Impact factor: 7.640

7.  Glutamine deprivation plus BPTES alters etoposide- and cisplatin-induced apoptosis in triple negative breast cancer cells.

Authors:  Lian Chen; Hengmin Cui; Jing Fang; Huidan Deng; Ping Kuang; Hongrui Guo; Xun Wang; Ling Zhao
Journal:  Oncotarget       Date:  2016-08-23

Review 8.  mTOR Regulation of Metabolism in Hematologic Malignancies.

Authors:  Simone Mirabilii; Maria Rosaria Ricciardi; Agostino Tafuri
Journal:  Cells       Date:  2020-02-11       Impact factor: 6.600

9.  Downregulation of Glutamine Synthetase, not glutaminolysis, is responsible for glutamine addiction in Notch1-driven acute lymphoblastic leukemia.

Authors:  Tra Ly Nguyen; Marie-Julie Nokin; Silvia Terés; Mercedes Tomé; Clément Bodineau; Oriane Galmar; Jean-Max Pasquet; Benoit Rousseau; Sebastian van Liempd; Juan Manuel Falcon-Perez; Elodie Richard; Elodie Muzotte; Hamid-Reza Rezvani; Muriel Priault; Marion Bouchecareilh; Isabelle Redonnet-Vernhet; Julien Calvo; Benjamin Uzan; Françoise Pflumio; Patricia Fuentes; Maria L Toribio; Abdel-Majid Khatib; Pierre Soubeyran; Piedad Del Socorro Murdoch; Raúl V Durán
Journal:  Mol Oncol       Date:  2021-02-13       Impact factor: 6.603

10.  PDHA1 gene knockout in prostate cancer cells results in metabolic reprogramming towards greater glutamine dependence.

Authors:  Yaqing Li; Xiaoran Li; Xiaoli Li; Yali Zhong; Yasai Ji; Dandan Yu; Mingzhi Zhang; Jian-Guo Wen; Hongquan Zhang; Mariusz Adam Goscinski; Jahn M Nesland; Zhenhe Suo
Journal:  Oncotarget       Date:  2016-08-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.